Injoy Heartburn Relief (Famotidine, Calcium Carbonate and Magnesium Hydroxide)
Brand Names: Injoy Heartburn Relief
Methodology & AI Transparency ⓘ
Injoy Heartburn Relief (Famotidine, Calcium Carbonate and Magnesium Hydroxide) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Formulated with active pharmaceutical ingredient Famotidine, Calcium Carbonate and Magnesium Hydroxide and registered by L.
- 2 Real-world patient consensus: Commercial Injoy Heartburn Relief monograph (10 mg/1 / 800 mg/1 Tablet, Chewable) cross-indexed with generic Famotidine, Calcium Carbonate and Magnesium Hydroxide for therapeutic equivalence review.
- 3 Typical cash cost range: Uninsured 30-day outlay compares $15.64 cash mean against $41.45 retail pharmacy pricing.
- 4 Top reported side effects / signs: Most commonly reported Injoy Heartburn Relief (Famotidine, Calcium Carbonate and Magnesium Hydroxide) tolerability events: dyspepsia (5.5%), nausea (8.4%), headache (7%).
Ask our AI Specialists anything about Injoy Heartburn Relief (Famotidine, Calcium Carbonate and Magnesium Hydroxide)
Injoy Heartburn Relief (Famotidine, Calcium Carbonate and Magnesium Hydroxide) Mechanism, CYP450 Pathways & DailyMed Monograph
Formulated with active pharmaceutical ingredient Famotidine, Calcium Carbonate and Magnesium Hydroxide and registered by L. Perrigo Company, Injoy Heartburn Relief operates as a over-the-counter branded histamine-2 receptor antagonist therapy (RxNorm 283641; NDC 0113-6023, 51316-407). Under 2022-09-07 FDA labeling for 10 mg/1 / 800 mg/1 Tablet, Chewable; 10 mg/1 / 165 mg/1 Tablet, Chewable, Use relieves heartburn associated with acid indigestion and sour stomach
Bioactive Famotidine, Calcium Carbonate and Magnesium Hydroxide within Injoy Heartburn Relief governs histamine-2 receptor antagonist target modulation with class-characteristic hepatorenal disposition. Commercialized across 10 mg/1 / 800 mg/1 Tablet, Chewable; 10 mg/1 / 165 mg/1 Tablet, Chewable (registered by L. Perrigo Company, SPL 2022-09-07), Injoy Heartburn Relief combines branded dosage-form consistency (NDC 0113-6023, 51316-407) with transparent cash-pay comparisons spanning $15.64 to $41.45.
With Steady-state plasma equilibrium reached over 9–20 hour t½ intervals for Injoy Heartburn Relief (Famotidine, Calcium Carbonate and Magnesium Hydroxide) residence kinetics and Approximately 57% to 69% enteral uptake across labeled Injoy Heartburn Relief (Famotidine, Calcium Carbonate and Magnesium Hydroxide) strengths bioavailability, Injoy Heartburn Relief (Famotidine, Calcium Carbonate and Magnesium Hydroxide) undergoes predominantly hepatic biotransformation with renal elimination of polar injoy heartburn relief (famotidine, calcium carbonate and magnesium hydroxide) conjugates and establishes therapeutic activity over maximum serum exposure occurs 2–4 hours after injoy heartburn relief (famotidine, calcium carbonate and magnesium hydroxide) dosing.
Standard adult regimens span 10 mg/1 / 800 mg/1 Tablet, Chewable, 10 mg/1 / 165 mg/1 Tablet, Chewable. Prescribers screen specifically against previous anaphylactoid or exfoliative reaction attributed to injoy heartburn relief (famotidine, calcium carbonate and magnesium hydroxide); clinical scenarios where histamine-2 receptor antagonist exposure from injoy heartburn relief (famotidine, calcium carbonate and magnesium hydroxide) poses unacceptable risk, while community micro-logs most frequently note nausea (8.4% of reports), headache (7% of reports), dizziness (6.1% of reports).
Verify medication reconciliation lists so Injoy Heartburn Relief (Famotidine, Calcium Carbonate and Magnesium Hydroxide) is not inadvertently duplicated with another histamine-2 receptor antagonist.
Unstandardized herbal extracts may interact pharmacodynamically with Injoy Heartburn Relief (Famotidine, Calcium Carbonate and Magnesium Hydroxide) maintenance therapy.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Previous anaphylactoid or exfoliative reaction attributed to Injoy Heartburn Relief (Famotidine, Calcium Carbonate and Magnesium Hydroxide)
- Clinical scenarios where histamine-2 receptor antagonist exposure from Injoy Heartburn Relief (Famotidine, Calcium Carbonate and Magnesium Hydroxide) poses unacceptable risk
Logged Side-Effect Incidence (6 Reports)
Injoy Heartburn Relief (Famotidine, Calcium Carbonate and Magnesium Hydroxide) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Injoy Heartburn Relief (Famotidine, Calcium Carbonate and Magnesium Hydroxide))
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Nonerosive Among 772 subjects, the mean percentage of heartburn-free nights at week 4 was 43.3% for placebo vs 59.9% for vonoprazan 10 mg (least squares [LS] mean difference = 16.5%, P < 0.0001) and 56.4% for vonoprazan 20 mg (LS mean... The American journal of gastroenterology • 2026-08-01 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 41081570 ↗ |
| Can This Approach Help? Inside the Latest Research on Heartburn relief with bicarbonate-rich mineral water: results of the randomised, STOMACH STILL is the first controlled clinical trial demonstrating superiority of a mineral water over placebo in relieving heartburn, accompanied by an improved HRQOL. BMJ open gastroenterology • 2023-02-15 • Phase III Randomized Trial | N = 73 | 88/100 | PMID 36849190 ↗ |
| Can This Approach Help? Inside the Latest Research on Randomised clinical trial: comparison of tegoprazan and placebo in non-erosive Tegoprazan 50 and 100 mg showed superior therapeutic efficacy compared with the placebo, as well as a favourable safety profile in patients with NERD. Alimentary pharmacology & therapeutics • 2021-08-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 34227708 ↗ |
Injoy Heartburn Relief (Famotidine, Calcium Carbonate and Magnesium Hydroxide) Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.0992/unit (~$2.98/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $41.45 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 6 Anonymous DotMD Community Micro-Logs | $15.64 / mo | View logs ↓ |
Injoy Heartburn Relief (Famotidine, Calcium Carbonate and Magnesium Hydroxide) Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Injoy Heartburn Relief (Famotidine, Calcium Carbonate and Magnesium Hydroxide) RxNorm Concept ID | 283641 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0992 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $41.45 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $15.64 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 86.00% Worth It (6 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Injoy Heartburn Relief (Famotidine, Calcium Carbonate and Magnesium Hydroxide) Patient Community, Cohort Filters & Dosage Logs
Cross-verified Injoy Heartburn Relief (Famotidine, Calcium Carbonate and Magnesium Hydroxide) (histamine-2 receptor antagonist) monograph synthesizing RxNorm 283641, openFDA FAERS signals, and $15.64–$41.45 cash benchmarks.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Injoy Heartburn Relief (Famotidine, Calcium Carbonate and Magnesium Hydroxide) community threads and patient logs by age, biological sex, dosage, and treatment duration.